Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Photochem Photobiol B ; 151: 285-96, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26355716

RESUMEN

Clinical studies demonstrated the effectiveness of laser therapy in the management of postmastectomy lymphedema, a discomforting disease that can arise after surgery/radiotherapy and gets progressively worse and chronic. However, safety issues restrict the possibility to treat cancer patients with laser therapy, since the effects of laser radiation on cancer cell behavior are not completely known and the possibility of activating postmastectomy residual cancer cells must be considered. This paper reports the results of an in vitro study aimed to investigate the effect of a class IV, dual-wavelength (808 nm and 905 nm), NIR laser system on the behavior of two human breast adenocarcinoma cell lines (namely, MCF7 and MDA-MB361 cell lines), using human dermal fibroblasts as normal control. Cell viability, proliferation, apoptosis, cell cycle and ability to form colonies were analyzed in order to perform a cell-based safety testing of the laser treatment in view of its potential application in the management of postmastectomy lymphedema. The results showed that, limited to the laser source, treatment conditions and experimental models used, laser radiation did not significantly affect the behavior of human breast adenocarcinoma cells, including their clonogenic efficiency. Although these results do not show any significant laser-induced modification of cancer cell behavior, further studies are needed to assess the possibility of safely applying NIR laser therapy for the management of postmastectomy lymphedema.


Asunto(s)
Linfedema del Cáncer de Mama/cirugía , Neoplasias de la Mama/patología , Terapia por Láser/métodos , Apoptosis , Linfedema del Cáncer de Mama/patología , Línea Celular Tumoral , Proliferación Celular , Supervivencia Celular , Femenino , Fibroblastos , Humanos , Terapia por Luz de Baja Intensidad/métodos , Células MCF-7 , Mastectomía/efectos adversos
2.
Pharmacol Res ; 59(6): 365-78, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19429468

RESUMEN

We describe here the main natural compounds used in cancer therapy and prevention, the historical aspects of their application and pharmacognosy. Two major applications of these compounds are described: as cancer therapeutics and as chemopreventive compounds. Both natural compounds, extracted from plants or animals or produced by microbes (antibiotics), and synthetic compounds, derived from natural prototype structures, are being used. We also focus on the molecular aspects of interactions with their recognized cellular targets, from DNA to microtubules. Some critical aspects of current cancer chemotherapy are also discussed, focusing on genetics and genomics, and the recent revolutionary theory of cancer: aneuploidy as the primum movens of cancer.


Asunto(s)
Anticarcinógenos/uso terapéutico , Antineoplásicos Fitogénicos/uso terapéutico , Antioxidantes/uso terapéutico , Productos Biológicos/uso terapéutico , Suplementos Dietéticos , Neoplasias/tratamiento farmacológico , Animales , Humanos , Neoplasias/prevención & control , Farmacognosia , Fitoterapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA